Publication | Closed Access

Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women

SclerostinSclerostin LevelsPharmacologyLong-term TreatmentMenopause Hormone TherapyMenopauseMedicineOsteoporosisWomen's HealthPostmenopausal Women